The innovative Fixed-Dose Combination will help improving the glycemic control among adult patients with insulin resistance, those whose diabetesis uncontrolled…
It also plans to expand to other states as well Cochin, October 04, 2021:The Hyderabad based 24 years old leading…
New Delhi, August 12, 2018: Pharma major Glenmark Pharmaceuticals on Friday reported consolidated net profit of ₹232.99 crore in the first…
Mumbai, April 21, 2018: Pharma Major, Glenmark Pharmaceuticals, on Tuesday announced the initiation of a Phase 2b clinical trial of GBR…
New Delhi, March 29, 2018: Management teams were generally optimistic on the outlook for domestic Indian markets, with sales growth…